Cervical cancer classification: Difference between revisions

Jump to navigation Jump to search
Line 3: Line 3:


==Overview==
==Overview==
Cervical cancer may be classified into many subtypes based on FIGO classification.
Cervical cancer may be classified into many subtypes based on [[FIGO]] classification.


==Classification ==
==Classification ==
Newly revised FIGO staging for cervical cancer, included pathological and imaging findings as well as clinical manifestations.<ref name="MatsuoMachida2019">{{cite journal|last1=Matsuo|first1=Koji|last2=Machida|first2=Hiroko|last3=Mandelbaum|first3=Rachel S.|last4=Konishi|first4=Ikuo|last5=Mikami|first5=Mikio|title=Validation of the 2018 FIGO cervical cancer staging system|journal=Gynecologic Oncology|volume=152|issue=1|year=2019|pages=87–93|issn=00908258|doi=10.1016/j.ygyno.2018.10.026}}</ref><ref name="BhatlaAoki2018">{{cite journal|last1=Bhatla|first1=Neerja|last2=Aoki|first2=Daisuke|last3=Sharma|first3=Daya Nand|last4=Sankaranarayanan|first4=Rengaswamy|title=Cancer of the cervix uteri|journal=International Journal of Gynecology & Obstetrics|volume=143|year=2018|pages=22–36|issn=00207292|doi=10.1002/ijgo.12611}}</ref><ref name="ChamiéBlasbalg2011">{{cite journal|last1=Chamié|first1=Luciana Pardini|last2=Blasbalg|first2=Roberto|last3=Pereira|first3=Ricardo Mendes Alves|last4=Warmbrand|first4=Gisele|last5=Serafini|first5=Paulo Cesar|title=Findings of Pelvic Endometriosis at Transvaginal US, MR Imaging, and Laparoscopy|journal=RadioGraphics|volume=31|issue=4|year=2011|pages=E77–E100|issn=0271-5333|doi=10.1148/rg.314105193}}</ref>
Newly revised [[FIGO]] staging for cervical cancer, included [[pathological]] and imaging findings as well as [[clinical]] manifestations.<ref name="MatsuoMachida2019">{{cite journal|last1=Matsuo|first1=Koji|last2=Machida|first2=Hiroko|last3=Mandelbaum|first3=Rachel S.|last4=Konishi|first4=Ikuo|last5=Mikami|first5=Mikio|title=Validation of the 2018 FIGO cervical cancer staging system|journal=Gynecologic Oncology|volume=152|issue=1|year=2019|pages=87–93|issn=00908258|doi=10.1016/j.ygyno.2018.10.026}}</ref><ref name="BhatlaAoki2018">{{cite journal|last1=Bhatla|first1=Neerja|last2=Aoki|first2=Daisuke|last3=Sharma|first3=Daya Nand|last4=Sankaranarayanan|first4=Rengaswamy|title=Cancer of the cervix uteri|journal=International Journal of Gynecology & Obstetrics|volume=143|year=2018|pages=22–36|issn=00207292|doi=10.1002/ijgo.12611}}</ref><ref name="ChamiéBlasbalg2011">{{cite journal|last1=Chamié|first1=Luciana Pardini|last2=Blasbalg|first2=Roberto|last3=Pereira|first3=Ricardo Mendes Alves|last4=Warmbrand|first4=Gisele|last5=Serafini|first5=Paulo Cesar|title=Findings of Pelvic Endometriosis at Transvaginal US, MR Imaging, and Laparoscopy|journal=RadioGraphics|volume=31|issue=4|year=2011|pages=E77–E100|issn=0271-5333|doi=10.1148/rg.314105193}}</ref>




FIGO staging of cancer of the cervix uteri (2018)  
FIGO staging of cancer of the [[cervix]] [[Uterine|uteri]] (2018)  
{| class="wikitable"
{| class="wikitable"
!Stage
!Stage
Line 15: Line 15:
|-
|-
|I
|I
|The carcinoma is strictly confined to the cervix (extension to the uterine corpus should be disregarded)
|The [[carcinoma]] is strictly confined to the [[cervix]] (extension to the [[uterine]] corpus should be disregarded)
|-
|-
|IA
|IA
|Invasive carcinoma that can be diagnosed only by microscopy, with maximum depth of invasion <5 mma
|Invasive [[carcinoma]] that can be diagnosed only by [[microscopy]], with maximum depth of invasion <5 mma
|-
|-
|IA1
|IA1
Line 24: Line 24:
|-
|-
|IA2
|IA2
|Measured stromal invasion ≥3 mm and <5 mm in depth
|Measured [[stromal]] invasion ≥3 mm and <5 mm in depth
|-
|-
|IB
|IB
|Invasive carcinoma with measured deepest invasion ≥5 mm (greater than Stage IA), lesion limited to the cervix uterib
|Invasive carcinoma with measured deepest invasion ≥5 mm (greater than Stage IA), lesion limited to the cervix uteri
|-
|-
|IB1
|IB1
Line 33: Line 33:
|-
|-
|IB2
|IB2
|Invasive carcinoma ≥2 cm and <4 cm in greatest dimension
|Invasive [[carcinoma]] ≥2 cm and <4 cm in greatest dimension
|-
|-
|IB3
|IB3
|Invasive carcinoma ≥4 cm in greatest dimension
|Invasive [[carcinoma]] ≥4 cm in greatest dimension
|-
|-
|II
|II
|The carcinoma invades beyond the uterus, but has not extended onto the lower third of the vagina or to the pelvic wall
|The carcinoma invades beyond the [[uterus]], but has not extended onto the lower third of the vagina or to the [[pelvic]] wall
|-
|-
|IIA
|IIA
Line 45: Line 45:
|-
|-
|IIA1
|IIA1
|Invasive carcinoma <4 cm in greatest dimension
|[[Invasive]] carcinoma <4 cm in greatest dimension
|-
|-
|IIA2
|IIA2
Line 51: Line 51:
|-
|-
|IIB
|IIB
|With parametrial involvement but not up to the pelvic wall
|With parametrial involvement but not up to the [[pelvic]] wall
|-
|-
|III
|III
|The carcinoma involves the lower third of the vagina and/or extends to the pelvic wall and/or causes hydronephrosis or nonfunctioning kidney and/or involves pelvic and/or para‐aortic lymph nodesc
|The [[carcinoma]] involves the lower third of the vagina and/or extends to the pelvic wall and/or causes [[hydronephrosis]] or nonfunctioning [[kidney]] and/or involves [[pelvic]] and/or para‐aortic [[lymph nodes]]
|-
|-
|IIIA
|IIIA
|The carcinoma involves the lower third of the vagina, with no extension to the pelvic wall
|The carcinoma involves the lower third of the vagina, with no extension to the [[pelvic]] wall
|-
|-
|IIIB
|IIIB
|Extension to the pelvic wall and/or hydronephrosis or nonfunctioning kidney (unless known to be due to another cause)
|Extension to the [[pelvic]] wall and/or [[hydronephrosis]] or nonfunctioning [[kidney]] (unless known to be due to another cause)
|-
|-
|IIIC
|IIIC
|Involvement of pelvic and/or para‐aortic lymph nodes, irrespective of tumor size and extent (with r and p notations)c
|Involvement of [[pelvic]] and/or para‐aortic [[lymph node]]<nowiki/>s, irrespective of [[tumor]] size and extent (with r and p notations)c
|-
|-
|IIIC1
|IIIC1
|Pelvic lymph node metastasis only
|[[Pelvic]] lymph node metastasis only
|-
|-
|IIIC2
|IIIC2
|Para‐aortic lymph node metastasis
|Para‐aortic [[lymph node]] metastasis
|-
|-
|IV
|IV
|The carcinoma has extended beyond the true pelvis or has involved (biopsy proven) the mucosa of the bladder or rectum. (A bullous edema, as such, does not permit a case to be allotted to Stage IV)
|The [[carcinoma]] has extended beyond the true [[pelvis]] or has involved (biopsy proven) the mucosa of the [[bladder]] or [[rectum]]. (A [[bullous]] edema, as such, does not permit a case to be allotted to Stage IV)
|-
|-
|IVA
|IVA
|Spread to adjacent pelvic organs
|Spread to adjacent [[pelvic]] organs
|-
|-
|IVB
|IVB

Revision as of 19:31, 20 February 2019

Cervical cancer Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Cervical Cancer from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Cervical Cancer During Pregnancy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Cervical cancer classification On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cervical cancer classification

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cervical cancer classification

CDC on Cervical cancer classification

Cervical cancer classification in the news

Blogs on Cervical cancer classification

Directions to Hospitals Treating Cervical cancer

Risk calculators and risk factors for Cervical cancer classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Cervical cancer may be classified into many subtypes based on FIGO classification.

Classification

Newly revised FIGO staging for cervical cancer, included pathological and imaging findings as well as clinical manifestations.[1][2][3]


FIGO staging of cancer of the cervix uteri (2018)

Stage Description
I The carcinoma is strictly confined to the cervix (extension to the uterine corpus should be disregarded)
IA Invasive carcinoma that can be diagnosed only by microscopy, with maximum depth of invasion <5 mma
IA1 Measured stromal invasion <3 mm in depth
IA2 Measured stromal invasion ≥3 mm and <5 mm in depth
IB Invasive carcinoma with measured deepest invasion ≥5 mm (greater than Stage IA), lesion limited to the cervix uteri
IB1 Invasive carcinoma ≥5 mm depth of stromal invasion, and <2 cm in greatest dimension
IB2 Invasive carcinoma ≥2 cm and <4 cm in greatest dimension
IB3 Invasive carcinoma ≥4 cm in greatest dimension
II The carcinoma invades beyond the uterus, but has not extended onto the lower third of the vagina or to the pelvic wall
IIA Involvement limited to the upper two‐thirds of the vagina without parametrial involvement
IIA1 Invasive carcinoma <4 cm in greatest dimension
IIA2 Invasive carcinoma ≥4 cm in greatest dimension
IIB With parametrial involvement but not up to the pelvic wall
III The carcinoma involves the lower third of the vagina and/or extends to the pelvic wall and/or causes hydronephrosis or nonfunctioning kidney and/or involves pelvic and/or para‐aortic lymph nodes
IIIA The carcinoma involves the lower third of the vagina, with no extension to the pelvic wall
IIIB Extension to the pelvic wall and/or hydronephrosis or nonfunctioning kidney (unless known to be due to another cause)
IIIC Involvement of pelvic and/or para‐aortic lymph nodes, irrespective of tumor size and extent (with r and p notations)c
IIIC1 Pelvic lymph node metastasis only
IIIC2 Para‐aortic lymph node metastasis
IV The carcinoma has extended beyond the true pelvis or has involved (biopsy proven) the mucosa of the bladder or rectum. (A bullous edema, as such, does not permit a case to be allotted to Stage IV)
IVA Spread to adjacent pelvic organs
IVB Spread to distant organs

References

  1. Matsuo, Koji; Machida, Hiroko; Mandelbaum, Rachel S.; Konishi, Ikuo; Mikami, Mikio (2019). "Validation of the 2018 FIGO cervical cancer staging system". Gynecologic Oncology. 152 (1): 87–93. doi:10.1016/j.ygyno.2018.10.026. ISSN 0090-8258.
  2. Bhatla, Neerja; Aoki, Daisuke; Sharma, Daya Nand; Sankaranarayanan, Rengaswamy (2018). "Cancer of the cervix uteri". International Journal of Gynecology & Obstetrics. 143: 22–36. doi:10.1002/ijgo.12611. ISSN 0020-7292.
  3. Chamié, Luciana Pardini; Blasbalg, Roberto; Pereira, Ricardo Mendes Alves; Warmbrand, Gisele; Serafini, Paulo Cesar (2011). "Findings of Pelvic Endometriosis at Transvaginal US, MR Imaging, and Laparoscopy". RadioGraphics. 31 (4): E77–E100. doi:10.1148/rg.314105193. ISSN 0271-5333.

Template:WH Template:WS